Development of patient derived xenograft (PDX) models in human immune-reconstituted mice to evaluate efficacy of immunotherapeutic agents in lung and breast cancer. (December 2016) - Izadi, H.; Yan, D.; Kato-Maves, Y.; Thatte, J.; Broudy, T.